Virtual Roundtable on Diversity in Clinical Trial Enrollment

Video recordings from the Virtual Roundtable on Diversity in Clinical Trial Enrollment were presented virtually on July 25, 2023.

Program Organizers

• Leisha A. Emens, MD, PhD – Ankyra Therapeutics (SITC President, SITC DEI Committee Chair)
• Chelsea C. Pinnix, MD, PhD – The University of Texas MD Anderson Cancer Center (SITC DEI Committee Member)
• Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
• John H. Stewart IV, MD, MBA, FACS – LSU-LCMC Health Cancer Center

Overview

The goal of the virtual Roundtable on Diversity in Clinical Trial Enrollment is to walk away with recommendations for specific actions each stakeholder in the clinical trial ecosystem can take to positively impact diversity in clinical trial enrollment. Representatives from each stakeholder group will participate in the roundtable, which will consist of a series of presentations and panels that highlight success stories and lessons learned in addressing implicit bias challenges, creating patient and community engagement and optimizing trial designs and operations that facilitate access to clinical trials for patients of diverse backgrounds. By enabling a conversation across stakeholders, SITC aims to carve a roadmap for the next steps each stakeholder group can take to increase diversity in all immuno-oncology clinical trials.

You can view the program details here.